WHO Chemical Risk Assessment Workshop on new and emerging risks to human health from chemicals RIVM is hosting an international workshop on new and emerging risks from chemicals on 20 and 21 February 2019.
Possible health risks due to exposure to chromium-6 at tROM project Tilburg Research by RIVM shows that the participants in the so-called tROM project, their supervisors and other people involved may have been exposed to chromium-6.
Kick off European Project VITAL: Vaccines and InfecTious diseases in the Ageing popuLation Recently, the EU-sponsored Vaccines and InfecTious diseases in the Ageing popuLation (VITAL) project was launched.
No health risks associated with foods and food supplements containing Krill and microalgae oils Consumption of foods and food supplements that contain oil from microalgae Schizochytrium sp. and Krill oil do not cause harm to our health.
No evidence of increased incidence of breast cancer with insulin glargine Insulin glargine is used in the treatment of diabetes.
Lower salt contents in some foods, but similar saturated fat contents Some foods contain less salt in 2014 compared with 2011. According to research by RIVM the salt content of bread was 21 percent lower in 2011.
Risk assessment of dyes and flame retardants; there’s room for improvement On request of the Dutch food and product safety authority, RIVM has developed a prioritization method for substances used in textile production.
RIVM designated as WHO Collaborating Centre Antimicrobial Resistance Epidemiology and Surveillance AMR is one of the major global challenges in infectious disease control.
Comparison of market authorization systems of medical devices in USA and Europe Medical devices are a group of products varying from relatively simple devices like plasters and wheelchairs to complex equipment like pacemakers and MRI scanners.
RIVM researchers win best paper award of the journal Risk Analysis RIVM researchers Arie Havelaar and Arno Swart received the prestigious Best Paper Award 2014 of the Society for Risk Analysis.